SCHEMBL21534078

SCHEMBL21534078

CN1CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.43
CA12 O43570 2/20 0.43
TTR P02766 1/20 0.43
CA7 P43166 1/20 0.43
CA14 Q9ULX7 1/20 0.43
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 1/20 0.42
MGLL Q99685 1/20 0.40
TSHR P16473 3/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
KEAP1 Q14145 1/20 0.36
LMNA P02545 1/20 0.36
CYP2A13 Q16696 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
HSD17B10 Q99714 1/20 0.35
HPGD P15428 1/20 0.35
MEN1 O00255 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15384649 1.00 SMN1; SMN2 (0.43) SMN1; SMN2CA12TTRCA7CA14
SCHEMBL6033426 1.00 SMN1; SMN2 (0.43) SMN1; SMN2CA12TTRCA7CA14
SCHEMBL11337084 1.00 SMN1; SMN2 (0.43) SMN1; SMN2CA12TTRCA7CA14
Dioxane SCHEMBL1260650 1.00 SMN1; SMN2 (0.43) SMN1; SMN2CA12TTRCA7CA14
SCHEMBL24525605 1.00 SMN1; SMN2 (0.43) SMN1; SMN2CA12TTRCA7CA14
SCHEMBL254989 1.00 SMN1; SMN2 (0.43) SMN1; SMN2CA12TTRCA7CA14
SCHEMBL25148134 1.00 SMN1; SMN2 (0.43) SMN1; SMN2CA12TTRCA7CA14
SCHEMBL2452972 1.00 SMN1; SMN2 (0.43) SMN1; SMN2CA12TTRCA7CA14
SCHEMBL12014324 1.00 SMN1; SMN2 (0.43) SMN1; SMN2CA12TTRCA7CA14
SCHEMBL2123718 0.96 CA12 (0.45) SMN1; SMN2CA12TTRCA7CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220193249-A1 Conjugates And Conjugating Reagents Comprising A Linker That Includes At Least Two (-CH2-CH2-O-) Units In A Ring POLYTHERICS LIMITED (GB) 2022-06-23 US disclosed
US-20190328893-A1 Conjugates And Conjugating Reagents Comprising A Linker That Includes At Least Two (-CH2-CH2-0-) Units In A Ring POLYTHERICS LIMITED (GB) 2019-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190328893-A1 Conjugates And Conjugating Reagents Comprising A Linker That Includes At Least Two (-CH2-CH2-0-) Units In A Ring BCR, CD2BP2, LANCL1 SMN1; SMN2 2898/4885CA12 574/4885TTR 1534/4885
US-20220193249-A1 Conjugates And Conjugating Reagents Comprising A Linker That Includes At Least Two (-CH2-CH2-O-) Units In A Ring BCR, CD2BP2, LANCL1 SMN1; SMN2 3092/4885CA12 594/4885TTR 1504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.